Simavi Vahip, Turkey

Ege University Medicine Faculty Department of Psychiatry
I was born in Cyprus. I graduated from Ege University Medicine Faculty (Izmir - Turkey) and had my residency training at the same university. Mood disorders, especially bipolar disorder and related phenomena such as bipolar depression and manic switch; classification in psychiatry, and training in psychiatry are among my main areas of interest. I am author in more than 130 papers and 20 books or book chapters in Turkish and in English. I am co-editor of “Treatment Guidelines for Bipolar Disorders” and “Source Book of Treatment Guidelines for Depression” published for Psychiatric Association of Turkey. I was the editor of the Turkish version of Bipolar Disorders (translation of the official ISBD journal) for 3 years. I was the founder and editor-in-chief of the Psychiatry Update / Journal of Continuing Education & Continuing Professional Development of Psychiatric Association of Turkey (2011-2014). I have founded and directed several inpatient and outpatient units at Ege University (Affective Disorders Unit (founded in 1986), Clinical Psychopharmacology and Research Inpatient Unit (founded in 1989), Affective Disorders and Research Inpatient Unit (founded in 1997). I have worked as the Residency Training Coordinator at the same department for many years. I was president of the Society for Bipolar Disorders of Turkey (ISBD affiliated) between 2010 and 2013. Also, I have been elected and served as member of the Board of Councillors of the International Society for Bipolar Disorder (ISBD) for two consecutive periods (2007-2011). I served as president (2014-2016) and vice-president (2011-2014) for the Psychiatric Association of Turkey (PAT). I had primary responsibility in organizing scientific meetings and congresses both internationally (e.g. International Conference on Mood Disorders / Close Encounters of Three Seas-Istanbul/2006; 5th Biennial Conference of the ISBD-Istanbul/2012) and nationally (Scientific Program Committee Chair in many National Congress of Psychiatry and other national meetings). I also shared the responsibility with EPA President Professor Danuta Wasserman as co-president of the first EPA-Council of NPAs Symposium (13-14 November 2014, Antalya) which has the title “Cultural, Educational and Economic Issues in Mental Health Care - Current challenges and future perspectives”. Currently, I am working as the director of the Affective Disorders Unit at Department of Psychiatry at Ege University. I am official representative of the Psychiatric Association of Turkey at the EPA. I was elected as the chair of the Steering Committee of the EPA-Council of the National Psychiatric Associations and also serving as Executive Committee member and Board member of the EPA.

Presenter of 4 Presentations

European 11:10 - 12:10

Optimal interaction within the Mental Health Workforces in the post-Covid times: European and international institutional and non-governmental views Roundtable discussion:

Educational 08:30 - 08:45

The Name “Schizophrenia”: Initiatives and Proposals from the National Psychiatric Associations - W049

ALL SESSIONS
Educational

Abstract

Abstract Body

Renaming schizophrenia which started from Japan has received heterogeneous reactions from all over the world. Some countries, associations and experts consider it as an opportunity to fight against stigma while others do not share this perspective. Reactions, initiatives and proposals collected from EPA (European Psychiatric Association) member National Psychiatric Associations (NPAs) will be summarized to facilitate the discussion. A survey, consisting of structured and semi-structured questions was sent to 44 EPA member NPAs from 40 countries. Main purpose of the survey was to search and collect the NPAs’ opinions on several perspectives including any previous or planned action for this issue, possible prediction on whether renaming could be effective on stigmatization in their countries and cultures, and any proposals as possible new names for schizophrenia. Also, NPAs had been requested to provide evaluations of their Psychosis or Schizophrenia Section members, or other experts from their countries via the same instrument. The collected data will be presented in this workshop to facilitate the discussion and to elaborate Europe-wide or country specific positions and needs on the issue.

Hide